Email Updates
Government Resource
Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.
October 10, 2018
US Food and Drug Administration; FDA.
Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.
Related Resources
